Patient-Related Benefits for Adults with Cochlear Implantation : A Multicultural Longitudinal Observational Study
Lenarz, Thomas (Medizinische Hochschule Hannover)
Muller, Lida (Tygerberg Hospital)
Czerniejewska-Wolska, Hanna (Poznań University of Medical Sciences)
Varela, Hector Vallés (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza)
Orús Dotú, César (Institut d'Investigació Biomèdica Sant Pau)
Durko, Marcin (Barlicki University Hospital)
Irujo, Alicia Huarte (Clinica Universitaria de Navarra)
Piszczatowski, Bartosz (Medical University of Bialystok)
Zadrożniak, Marek (Medical University of Lublin)
Irwin, Colin (Cochlear AG)
Graham, Petra L. (Macquarie University)
Wyss, Josie (Cochlear AG)
Universitat Autònoma de Barcelona

Fecha:	2017
Resumen:	To assess subjectively perceived, real-world benefits longitudinally for unilateral cochlear implant (CI) recipients in a multinational population treated routinely. To identify possible predictors of self-reported benefits. This was a prospective, multicenter, repeated-measures study. Self-assessment of performance at preimplantation and postimplantation at 1, 2, and 3 years using standardized, validated, local language versions of the Speech, Spatial, and Qualities of Hearing Scale (SSQ), and the Health Utilities Index Mark 3 (HUI3) was performed. Outcomes were analyzed using a longitudinal mixed-effects model incorporating country effect. Patient demographics were explored for associations with change over time. Two hundred ninety-one routinely treated, unilateral CI recipients, aged 13-81 years, from 9 clinics across 4 countries. Highly significant improvements were observed for all outcome measures (p < 0. 0001). Postimplantation, mean outcome scores remained stable beyond 1 year, with notable individual variability. A significant association for one or more outcomes with preimplantation contralateral hearing aid use, telephone use, age at implantation, implantation side, preimplantation comorbidities, dizziness, and tinnitus was observed (p < 0. 004). Longitudinal benefits of CI treatment can be measured using clinically standardized self-assessment tools to provide a holistic view of patient-related benefits in routine clinical practice for aggregated data from multinational populations. Self-reported outcomes can provide medical-based evidence regarding CI treatment to support decision-making by health service providers.
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	Health Utilities Index Mark 3 ; Health utility ; Hearing benefits ; Hearing outcomes ; Observational study ; Patient registry ; Patient-related benefit ; Quality of life ; Speech ; Spatial ; Qualities of Hearing Scale
Publicado en:	Audiology and Neurotology, Vol. 22 Núm. 2 (january 2017) , p. 61-73, ISSN 1421-9700

DOI: 10.1159/000477533
PMID: 28719901

13 p, 254.2 KB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados